Corpus ID: 21071735

Identification and Management of Peripartum Depression.

@article{Langan2016IdentificationAM,
  title={Identification and Management of Peripartum Depression.},
  author={Robert C. Langan and Andrew J Goodbred},
  journal={American family physician},
  year={2016},
  volume={93 10},
  pages={
          852-8
        }
}
Peripartum depression affects up to one in seven women and is associated with significant maternal and neonatal morbidity if untreated. A history of depression is the strongest risk factor for developing peripartum depression. The U.S. Preventive Services Task Force recommends screening pregnant and postpartum women for depression. Both two-step and one-step screening strategies are effective in identifying peripartum depression. Peripartum depression should be distinguished from the baby blues… Expand
Antidepressants and recurrence of depression in the postpartum period
TLDR
The findings of this study align with research which suggests that the postpartum period is a particularly vulnerable time for recurrence of depression, and suggest that this remains the case regardless of antidepressant treatment. Expand
Postpartum Care: An Approach to the Fourth Trimester.
TLDR
Care should initially focus on acute needs and risks for morbidity and mortality and then transition to care for chronic conditions and health maintenance, and preventive counseling should be offered to women at high risk. Expand
Prevalence of maternal psychological disorders after immediate postpartum haemorrhage: a repeated cross-sectional study - the PSYCHE* study protoco
TLDR
Findings from the study will be useful for individualising medical follow-up after childbirth, especially for woman who experienced a PPH, but also more generally in increasing birth professionals' awareness of effects of trauma. Expand
Perinatal Mood and Anxiety Disorders, Stigma, and Social Support among Postpartum Women
Purpose/Aims: The purpose of this descriptive, correlational, cross-sectional study was to examine the relationships among perinatal mood and anxiety disorder (PMAD) symptomatology, selectExpand
Screening for postpartum anxiety: A quality improvement project to promote the screening of women suffering in silence.
TLDR
The Edinburgh Postpartum Depression Scale -3A is a valid, easy-to-use tool which should be considered for use in clinical practice and Modification of the electronic health record can serve as an important impetus triggering screening and treatment. Expand
Selective Serotonin Reuptake Inhibitors as First‐Line Antidepressant Therapy for Perinatal Depression Symbol
TLDR
The purpose of this article is to assist providers to select the safest, most effective selective serotonin reuptake inhibitor (SSRI) as the first‐line antidepressant during pregnancy and lactation. Expand
Retinoids, anxiety and peripartum depressive symptoms among Chinese women: a prospective cohort study
TLDR
A high prevalence of anxiety and depressive symptoms tended to persist in Chinese women during the peripartum period, which requires that large sample studies be conducted in future with a longer-term follow-up period in order to confirm its results. Expand
Prevalence and Associated Factors of Postpartum Anxiety and Depression Symptoms Among Women in Shanghai, China.
TLDR
The findings from this research provide a better understanding of factors associated with PPA and PPD symptoms and will help guide personalized approaches to the management of postpartum anxiety and depression. Expand
Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations
TLDR
Clinical trials demonstrated that brexanolone significantly reduces depression scores in women with moderate to severe PPD, and a REMS program will be put in place to mitigate the risk of adverse events. Expand
Perinatal Loss: The Impact on Maternal Mental Health
TLDR
This review aims to define psychological reactions associated with perinatal loss, examine psychotherapy and psychopharmacologic treatments for psychiatric morbidities, discuss interpregnancy interval following perinnatal loss, and highlight brief, psychological interventions that can be implemented by maternal health providers. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
Diagnosis, Pathophysiology, and Management of Mood Disorders in Pregnant and Postpartum Women
TLDR
The goal of this review is to synthesize essential information on depressive illness in the perinatal period with a focus on its most common and severe presentations, major depressive disorder and bipolar disorder. Expand
Postpartum major depression.
TLDR
If left untreated, postpartum major depression can lead to poor mother-infant bonding, delays in infant growth and development, and an increased risk of anxiety or depressive symptoms in the infant later in life. Expand
Perinatal depression: prevalence, screening accuracy, and screening outcomes.
TLDR
Although many screening instruments have been developed or modified to detect major and minor depression in pregnant and newly delivered women, the evidence on their screening accuracy relative to a reference standard has yet to be systematically reviewed and assessed. Expand
Effect of oestradiol on postpartum depression
TLDR
Oestradiol may be causally related to postpartum depression and have significance in the treatment of this condition. Expand
Incorporating Recognition and Management of Perinatal and Postpartum Depression Into Pediatric Practice
TLDR
Pediatric practices, as medical homes, can establish a system to implement postpartum depression screening and to identify and use community resources for the treatment and referral of the depressed mother and support for the mother-child (dyad) relationship. Expand
Hypnosis during pregnancy, childbirth, and the postnatal period for preventing postnatal depression.
TLDR
There was no evidence available from randomised controlled trials to assess the effectiveness of hypnosis during pregnancy, childbirth, and the postnatal period for preventing postnatal depression. Expand
A review of postpartum psychosis.
TLDR
The data suggest that postpartum psychosis is an overt presentation of bipolar disorder that is timed to coincide with tremendous hormonal shifts after delivery, which can lead to devastating consequences in which the safety and well-being of the affected mother and her offspring are jeopardized. Expand
Oestrogens and progestins for preventing and treating postpartum depression.
TLDR
Oestrogen therapy was associated with a greater improvement in depression scores than placebo among women with severe depression, and synthetic progestogens should be used with significant caution in the postpartum period. Expand
Postpartum Depression Screening: Importance, Methods, Barriers, and Recommendations for Practice
TLDR
Postpartum depression screening improves recognition of the disorder, but improvement in clinical outcomes requires enhanced care that ensures adequate treatment and follow-up. Expand
Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective survey of the MATQUID cohort
TLDR
Assessing whether anxiety disorder (AD) during pregnancy is an independent predictor of intensity of postnatal depressive symptoms found that women with pregnancy AD were nearly three times more likely to present with intense postnatal depression symptoms. Expand
...
1
2
3
4
5
...